VXRT Vaxart, Inc.: Accounting Value per Share

Graphic logo of Vaxart (VXRT)

Vaxart, Inc. (VXRT) is betting on the efficacy of tablet-based medications and the simplification of logistics. The company is scientifically valued for its commitment to painless immunization, and its current strategy focuses on scaling its platform against norovirus. The average book value per share on the GURU.Markets chart reflects the real value of net assets, with the indicator reaching the level of 0.20.

Vaxart Corp (VXRT): Share Book Value from 07/04/2022 to 07/19/2025

Vaxart Inc. - analytical breakdowns and key metrics (VXRT)

- price and consensus price forecast:
Price Chart Vaxart Corp|VXRT - Fair Value Consensus
- market capitalization data:
Market Valuation Vaxart, Inc.|VXRT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Vaxart|VXRT - Net Asset Value|Market Capitalization to Book Value Ratio vaxart.com|VXRT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Vaxart, Inc.|VXRT - Long-Term Debt to Capital|Short-Term Debt to Equity Vaxart Corp|VXRT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Vaxart, Inc.
Fundamental company valuation:vaxart.com - VXRT
Manufactured products of Vaxart Corp

This metric reflects the company's net equity per share after deducting all liabilities, serving as an indicator of the business's intrinsic value. For Vaxart, Inc. (VXRT), which retains key virologists through stock option programs, the book value per common share demonstrates asset resilience, which is critical for funding clinical phases and providing a hedge against bankruptcy during periods of market volatility.

Competitors of Vaxart, Inc. (VXRT)

Net Assets per Single Share Gilead Sciences Inc (GILD)|Cidara Therapeutics Corp (CDTX) - Accounting Value of a Share|NVAX - Accounting Value per Share|CVAC (curevac.com) - Book Price of a Share|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|Invivyd Inc - Book Value per Share|Net Assets per Single Share Enanta Pharmaceuticals, Inc. (ENTA)|INO: Accounting Value of a Share|HLVX (HilleVax Corp) - Net Assets per Single Share|Kalaris Tx (KLRS) - Accounting Value per Share|DYAI (Dyadic International Inc) - Book Value per Share|Book Value per Share NanoViricides Corp (NNVC)|Talphera (TLPH) - Accounting Value per Share|Accounting Value of a Share Cocrystal Pharma Inc COCP|Accounting Value per Share Traws Pharma TRAW|Net Assets per Single Share Dogwood Therapeutics Inc. DWTX|Book Value per Share QLGN (Qualigen Therapeutics)|ALVR: Net Assets per Share|Net Assets per Single Share vbivaccines.com VBIV|Accounting Value of a Share Virios Therapeutics, Inc.